KLOW components are not approved for athletes, sports use, or human performance enhancement
IV (Intravenous) Injections Administered directly into the bloodstream at a clinic
Los fabricantes deben comprobar la situacin reglamentaria local de cualquier declaracin segn el uso previsto de sus productos y son los nicos responsables de la comercializacin de sus productos acabados de conformidad con todas las leyes vigentes
It has an IC50 of 1.5pM, minimal off targets and high stability
When this delicate balance tips toward excessive breakdown, conditions such as osteopenia and osteoporosis can develop, leading to increased fracture risk and declining quality of life
Woltjer RL, Nghiem W, Maezawa I, Milatovic D, Vaisar T, Montine KS et al